3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
52
Leukemia, Myeloid, Acute
49
Lymphoma, Non-Hodgkin
43
Precursor Cell Lymphoblastic Leukemia-Lymphoma
39
Lymphoma
37
Leukemia
35
Hodgkin Disease
35
Myelodysplastic Syndromes
33
Lymphoma, Mantle-Cell
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Lymphoma, Large B-Cell, Diffuse
17
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Burkitt Lymphoma
17
Lymphoma, Follicular
12
Hematologic Neoplasms
12
Neoplasms, Plasma Cell
11
Congenital Abnormalities
11
Lymphoma, B-Cell, Marginal Zone
10
Leukemia, Biphenotypic, Acute
9
Breast Neoplasms
9
Myeloproliferative Disorders
8
Lymphoma, Large-Cell, Immunoblastic
8
Anemia, Refractory, with Excess of Blasts
8
Recurrence
7
Leukemia, Myelomonocytic, Juvenile
7
Leukemia, Myelomonocytic, Chronic
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Graft vs Host Disease
6
Sarcoma
5
Interventions
ponatinib
4
pembrolizumab
3
Rituximab
3
Gemcitabine
3
Cyclophosphamide
3
130-nm albumin-bound paclitaxel
3
pralsetinib
2
napabucasin
2
Vincristine
2
Prednisone
2
Irinotecan
2
Imatinib Mesylate
2
Etoposide
2
Doxorubicin
2
Carboplatin
2
Brentuximab Vedotin
2
tetulomab tetraxetan lu-177
1
ruxolitinib
1
ricolinostat
1
pomalidomide
1
pamiparib
1
nirogacestat
1
nilotinib
1
ibritumomab tiuxetan
1
denileukin diftitox
1
bosutinib
1
blinatumomab
1
Vorinostat
1
Temozolomide
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms by Histologic Type
×
Granulocyte Colony-Stimulating Factor
×
Clear all
No trials found.